14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 31, 2024 Sell 7 525 Thackray Helen M. Common Stock
Feb 29, 2024 Buy 999 Milano Vincent Common Stock
Feb 29, 2024 Buy 999 Heggie Theresa Common Stock
Jan 03, 2024 Sell 20 000 Stonehouse Jon P Common Stock
Jan 03, 2024 Buy 10 000 Stonehouse Jon P Common Stock
Dec 19, 2023 Sell 5 580 Thackray Helen M. Common Stock
Dec 19, 2023 Sell 14 089 Stonehouse Jon P Common Stock
Dec 19, 2023 Sell 2 482 Gayer Charles K Common Stock
Dec 19, 2023 Sell 2 482 Doyle Anthony Common Stock
Dec 19, 2023 Sell 2 482 Barnes Alane P Common Stock
Dec 14, 2023 Buy 51 000 Thackray Helen M. Common Stock
Dec 14, 2023 Sell 3 031 Thackray Helen M. Common Stock
Dec 14, 2023 Buy 238 000 Thackray Helen M. Emp. Stock Option (Right to Buy)
Dec 14, 2023 Buy 127 500 Stonehouse Jon P Common Stock
Dec 14, 2023 Sell 13 592 Stonehouse Jon P Common Stock
Dec 14, 2023 Buy 595 000 Stonehouse Jon P Emp. Stock Option (Right to Buy)
Dec 14, 2023 Buy 34 000 Gayer Charles K Common Stock
Dec 14, 2023 Sell 5 840 Gayer Charles K Common Stock
Dec 14, 2023 Buy 158 500 Gayer Charles K Emp. Stock Option (Right to Buy)
Dec 14, 2023 Buy 34 000 Doyle Anthony Common Stock
Dec 14, 2023 Sell 5 475 Doyle Anthony Common Stock
Dec 14, 2023 Buy 158 500 Doyle Anthony Emp. Stock Option (Right to Buy)
Dec 14, 2023 Buy 64 000 Barnes Alane P Common Stock
Dec 14, 2023 Sell 4 015 Barnes Alane P Common Stock
Dec 14, 2023 Buy 158 500 Barnes Alane P Emp. Stock Option (Right to Buy)
Nov 30, 2023 Buy 956 Milano Vincent Common Stock
Nov 30, 2023 Buy 956 Heggie Theresa Common Stock
Aug 31, 2023 Buy 791 Milano Vincent Common Stock
Aug 31, 2023 Buy 791 Heggie Theresa Common Stock
Jun 15, 2023 Sell 4 000 Sanders Machelle Common Stock
Jun 14, 2023 Sell 12 866 Hutson Nancy J Common Stock
Jun 13, 2023 Sell 25 000 Stonehouse Jon P Common Stock
Jun 13, 2023 Buy 39 072 Levin Alan G Automatic Stock Option Grant
Jun 13, 2023 Buy 16 745 Levin Alan G Common Stock
Jun 13, 2023 Buy 16 745 Lee Kenneth B Jr Common Stock
Jun 13, 2023 Buy 39 072 Lee Kenneth B Jr Automatic Stock Option Grant
Jun 13, 2023 Buy 39 072 Galson Steven K Automatic Stock Option Grant
Jun 13, 2023 Buy 16 745 Galson Steven K Common Stock
Jun 13, 2023 Buy 16 745 Aselage Steve Common Stock
Jun 13, 2023 Buy 39 072 Aselage Steve Automatic Stock Option Grant
Jun 13, 2023 Buy 39 072 Sanders Machelle Automatic Stock Option Grant
Jun 13, 2023 Buy 16 745 Sanders Machelle Common Stock
Jun 13, 2023 Buy 16 745 Milano Vincent Common Stock
Jun 13, 2023 Buy 39 072 Milano Vincent Automatic Stock Option Grant
Jun 13, 2023 Buy 16 745 Hutson Nancy J Common Stock
Jun 13, 2023 Buy 39 072 Hutson Nancy J Automatic Stock Option Grant
Jun 13, 2023 Buy 39 072 Mckee Amy E Automatic Stock Option Grant
Jun 13, 2023 Buy 16 745 Mckee Amy E Common Stock
Jun 13, 2023 Buy 16 745 Heggie Theresa Common Stock
Jun 13, 2023 Buy 39 072 Heggie Theresa Automatic Stock Option Grant
Jun 13, 2023 Buy 39 072 Abercrombie George B Automatic Stock Option Grant
Jun 13, 2023 Buy 16 745 Abercrombie George B Common Stock
May 31, 2023 Buy 680 Milano Vincent Common Stock
May 31, 2023 Buy 1 360 Levin Alan G Common Stock
May 31, 2023 Buy 680 Heggie Theresa Common Stock
Apr 03, 2023 Sell 7 000 Thackray Helen M. Common Stock
Mar 21, 2023 Buy 31 055 Stonehouse Jon P Common Stock
Mar 21, 2023 Sell 31 055 Stonehouse Jon P Emp. Stock Option (Right to Buy)
Feb 28, 2023 Buy 635 Milano Vincent Common Stock
Feb 28, 2023 Buy 2 259 Ingram Robert Alexander Common Stock
Feb 28, 2023 Buy 635 Heggie Theresa Common Stock
Feb 28, 2023 Buy 1 271 Levin Alan G Common Stock
Feb 01, 2023 Buy 100 000 Stonehouse Jon P Common Stock
Feb 01, 2023 Sell 100 000 Stonehouse Jon P Common Stock
Feb 01, 2023 Sell 100 000 Stonehouse Jon P Emp. Stock Option (Right to Buy)
Jan 31, 2023 Buy 15 000 Lee Kenneth B Jr Common Stock
Jan 31, 2023 Sell 15 000 Lee Kenneth B Jr Automatic Stock Option Grant
Dec 29, 2022 Sell 10 000 Stonehouse Jon P Common Stock
Dec 29, 2022 Buy 5 000 Stonehouse Jon P Common Stock
Dec 19, 2022 Buy 34 000 Barnes Alane P Common Stock
Dec 19, 2022 Buy 158 500 Barnes Alane P Emp. Stock Option (Right to Buy)
Dec 19, 2022 Buy 238 000 Thackray Helen M. Emp. Stock Option (Right to Buy)
Dec 19, 2022 Buy 81 000 Thackray Helen M. Common Stock
Dec 19, 2022 Buy 127 500 Stonehouse Jon P Common Stock
Dec 19, 2022 Buy 595 000 Stonehouse Jon P Emp. Stock Option (Right to Buy)
Dec 19, 2022 Buy 5 900 Jones Michael L Common Stock
Dec 19, 2022 Buy 8 500 Jones Michael L Emp. Stock Option (Right to Buy)
Dec 19, 2022 Buy 34 000 Gayer Charles K Common Stock
Dec 19, 2022 Buy 158 500 Gayer Charles K Emp. Stock Option (Right to Buy)
Dec 19, 2022 Buy 34 000 Doyle Anthony Common Stock
Dec 19, 2022 Buy 158 500 Doyle Anthony Emp. Stock Option (Right to Buy)
Dec 15, 2022 Sell 14 100 Stonehouse Jon P Common Stock
Dec 15, 2022 Sell 3 125 Thackray Helen M. Common Stock
Dec 15, 2022 Sell 5 700 Doyle Anthony Common Stock
Dec 15, 2022 Sell 6 100 Gayer Charles K Common Stock
Dec 15, 2022 Sell 445 Jones Michael L Common Stock
Dec 15, 2022 Sell 4 175 Barnes Alane P Common Stock
Dec 02, 2022 Buy 82 656 Stonehouse Jon P Common Stock
Dec 02, 2022 Sell 82 656 Stonehouse Jon P Common Stock
Dec 02, 2022 Sell 82 656 Stonehouse Jon P Emp. Stock Option (Right to Buy)
Dec 01, 2022 Buy 8 600 Jones Michael L Common Stock
Dec 01, 2022 Sell 8 600 Jones Michael L Common Stock
Dec 01, 2022 Sell 8 600 Jones Michael L Emp. Stock Option (Right to Buy)
Dec 01, 2022 Buy 214 917 Stonehouse Jon P Common Stock
Dec 01, 2022 Sell 214 917 Stonehouse Jon P Emp. Stock Option (Right to Buy)
Nov 30, 2022 Buy 421 Heggie Theresa Common Stock
Nov 30, 2022 Buy 421 Milano Vincent Common Stock
Nov 30, 2022 Buy 842 Levin Alan G Common Stock
Nov 30, 2022 Buy 1 497 Ingram Robert Alexander Common Stock
Nov 14, 2022 Buy 50 000 Babu Yarlagadda S Common Stock
INSIDER POWER
72.602
Last 100 transactions
Buy: 4 343 991 | Sell: 822 588 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 72.602.

In total, the insiders bought 4 343 991 and sold 822 588 BCRX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT